INVEGA (Janssen Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the INVEGA drug offered from Janssen Pharmaceuticals, Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: paliperidone
SUBSTANCE NAME: PALIPERIDONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Atypical Antipsychotic [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-12-19
END MARKETING DATE: 0000-00-00


INVEGA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionINVEGA from Janssen Pharmaceuticals, Inc.
LABELER NAME: Janssen Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3(mg/1)
START MARKETING DATE: 2006-12-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50458-550_bb9d092b-52c8-467d-bb3c-ea5f60b5da5c
PRODUCT NDC: 50458-550
APPLICATION NUMBER: NDA021999

Other PALIPERIDONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Paliperidone
Avera McKennan HospitalINVEGA
Carilion Materials ManagementPaliperidone
Janssen Pharmaceuticals, Inc.INVEGA
Mylan Institutional Inc.Paliperidone
Mylan Pharmaceuticals Inc.Paliperidone
Patriot Pharmaceuticals, LLCPaliperidone
Rebel Distributors CorpINVEGA
TYA PharmaceuticalsINVEGA